Efficacy and safety of the C5 inhibitor crovalimab in complement inhibitor‐naive patients with PNH (COMMODORE 3): A multicenter, Phase 3, single‐arm study.

Autor: Liu, Hui, Xia, Linghui, Weng, Jianyu, Zhang, Fengkui, He, Chuan, Gao, Sujun, Jia, Jinsong, Chang, Alice C., Lundberg, Pontus, Shi, Jane, Sima, Camelia S., Sostelly, Alexandre, Sreckovic, Sasha, Xiao, Zhenyu, Zhang, Zilu, Fu, Rong
Zdroj: American Journal of Hematology; Sep2023, Vol. 98 Issue 9, p1407-1414, 8p
Databáze: Complementary Index